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Yamazaki and colleagues [1] have presented an interesting retrospective cohort study on 
the safety and feasibility of the use of a hyaluronate carboxymethylcellulose (HCM)-based 
bioresorbable membrane to reduce adhesions at the second stage of a two-stage 
pancreaticoduodenectomy performed 4 to 8 weeks after the initial resection. The authors 
have reported reduced adhesions, thereby facilitating the second-stage reconstruction. 
There was also formation of good granulation tissue around the exteriorized pancreatic 
fistula despite the presence of the HCM-based membrane. The authors used operative 
duration and blood loss at the second stage as markers for the efficacy of the HCM-based 
membrane, but found no difference between the HCM-based membrane group (n=61) and 
the historical control group in which the HCM-based membrane was not used (n=145) in the 
rate of pancreatic fistula formation. 
Although the efficacy of HCM-based membranes in reducing intra-abdominal adhesions 
after surgery is well established [2], there are no previous reports on their use in two-stage 
pancreatic surgery. However, this study [1] is limited by the inherent bias associated with 
retrospective cohort studies. Additionally, it is restricted by the fact that a two-stage 
pancreaticoduodenectomy for cancer is not standard procedure across the vast majority of 
centres outside Japan. The two-stage procedure with planned readmission was directed 
towards patients at high-risk for a pancreatic anastomotic leak and the authors demonstrate 
an excellent 0% mortality, albeit with much longer hospital stays than seen in other centres. 
There are several issues related to the study [1]. Although a two-stage 
pancreaticoduodenectomy may be justified in certain situations, such as damage-limitation 
surgery for pancreatic trauma [3], the drawbacks of the procedure have been highlighted 






























































previously [4] and include increased morbidity, barriers to the delivery of adjuvant therapy, 
and a negative impact on both health economics and quality-of life. It is remarkable that the 
vast majority of procedures performed in this study [1] were two-stage operations [213 
(87.3%) two-stage versus 31 (12.7%) single-stage over 7 years]. It is difficult to reconcile this 
with the contention that two-stage procedures were performed only for patients deemed to 
be at high-risk of pancreatic leak. The authors did not perform an assessment of the risk of 
pancreatic leak using scoring systems to inform this decision. Cumulatively, the complication 
rate across the two-stage procedures was higher than rates for a single stage procedure 
when compared with the majority of high-volume pancreatic centres [5]. The additional 
comorbid burden placed by a second procedure with an iatrogenic external fistula as well as 
the obstacle this would place in the provision of adjuvant chemotherapy and the negative 
impact on the individual patient’s quality of life complicates the picture. It is also important 
to note that seven patients were excluded from the analysis because the second operation 
was not performed for a variety of reasons that included disease progression (n=5), cerebral 
infarction (n=1) and patient refusal (n=1).
While we appreciate that the use of the HCM-based membrane reduced adhesions at the 
second stage, it is difficult to rationalise how the presence of the HCM-based membrane 
would reduce adhesions on one hand and promote good external fistulisation with 
granulation tissue formation on the other. As a marker of ease of second stage laparotomy, 
the reduction in blood loss in the HCM-based membrane group compared with the control 
group, although statistically significant, was clinically negligible (36 vs. 58 ml). There was a 
longer operative duration in the control group than in the HCM-based membrane group 
(151 vs. 105 min) for the second stage operation. However, it is difficult to envisage how the 






























































second stage reconstruction could have been performed at the lower limit of the quoted 
range of the operative duration of 30 minutes in both groups. Nevertheless, despite 
concerns about the need for a two-stage pancreaticoduodenectomy, this study is useful in 
demonstrating that HCM-based membranes can be used safely in patients who undergo this 
procedure.
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